Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONSET-2: OC-01 (Varenicline) Nasal Spray for Dry Eye Disease
NCT04036292Phase 3Completed
- Sponsor
- Oyster Point Pharma
- Start
- Jul 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline + nicotine patch in dry eye disease (DED), sponsored by Oyster Point Pharma. Started Jul 2019; status: completed.
02
Drugs
varenicline + nicotine patch
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04036292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04036292.